Results 51 to 60 of about 38,559 (244)

The Psychedelic Influence on Philosophy [PDF]

, 2016
A mildly chronological overview of the philosophers who may have been inspired by the use of psychoactive chemicals, inc. Plato, de Quincey, Davy, Schopenhauer, Nietzsche, James, Bergson, Benjamin, Jünger, Paz, Marcuse, Sartre, Foucault; and a mention of
Sjöstedt-H., Peter
core  

The Physicalist Worldview as Neurotic Ego-Defense Mechanism [PDF]

, 2016
The physicalist worldview is often portrayed as a dispassionate interpretation of reality motivated purely by observable facts. In this article, ideas of both depth and social psychology are used to show that this portrayal may not be accurate ...
Kastrup, Bernardo
core   +2 more sources

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden, Michael Kelleher, Fiona Dunbar, Anna O. Ermakova, Luke Mitcheson, Claire Roberts, James J. Rucker, Gemma Scott, Ivan Saeger, Francesca Small, Mathieu Seynaeve   +10 more
wiley   +1 more source

Review of Listening Into the Heart of Things-on MDMA and LSD by Samuel Widmer (1989) [PDF]

, 2016
This is an early volume from a much respected psychedelic psychotherapist. He has written several other books since this one but until recently none of his books were on Amazon and still you can only find a German edition and a Spanish one (from 1993 ...
Starks, Michael
core  

The psychoactive effects of repeated ketamine infusions and their mechanistic role in the treatment of alcohol use disorder: Secondary analysis of a randomised controlled trial

Addiction, EarlyView.
Abstract Background and aims Ketamine assisted psychotherapy is a promising new treatment for alcohol use disorder (AUD). The psychoactive effects of repeated intravenous (IV) ketamine infusions in people with AUD and their mechanistic role in treating AUD are largely unknown.
Cassie Bloy, Ananya Sarma, Bethan Marsh, Lorna Hardy, Meryem Grabski, Merve Mollaahmetoglu, Joshua Shotton, Shamhethan Bhaskaran, Anne Lingford‐Hughes, H. Val Curran, Celia Morgan, Will Lawn   +11 more
wiley   +1 more source

Evidence that Moved Psychedelic Medicine from the Fringe to the Mainstream in 2022

European Psychiatry, 2023
Interest in possible clinical uses for psychedelic drugs has grown steadily over the past decade. Although impressive findings from small studies stimulated considerable speculation and provided a strong justification for further study of psychedelic ...
M. Bogenschutz
doaj   +1 more source

Prevalence of psychosis in black ethnic minorities in Britain: analysis based on three national surveys [PDF]

, 2014
Purpose A considerable excess of psychosis in black ethnic minorities is apparent from clinical studies, in Britain, as in other developed economies with white majority populations. This excess is not so marked in population surveys.
A Chakraborty, DW Hosmer, EM Green, H Meltzer, J McGrath, J Nazroo, J Nazroo, J Perälä, JB Kirkbride, JK Wing, L Kish, LN Robins, N Singleton, N Singleton, Nicola Spiers, P Fearon, P McCrone, Paul Bebbington, PE Bebbington, PE Bebbington, PE Bebbington, PG Arbogast, R Jenkins, Rachel Jenkins, S Karlsen, S Marwaha, S McManus, Sally McManus, Simon Dein, T Brugha, T Sturmer, Tarik Qassem, TJ Bosqui, World Health Organization   +33 more
core   +3 more sources

Changes over time in hallucinogen‐related emergency department visits in Ontario, Canada

Addiction, EarlyView.
Abstract Background and aims Recent increasing interest in hallucinogens has underscored the critical gaps in our understanding of their adverse health effects and healthcare usage over time. The current study aimed to examine changes in emergency department (ED) visit rates involving hallucinogens, clinical outcomes of visits and the characteristics ...
Daniel T. Myran, Rachael MacDonald‐Spracklin, Alexander R. Levesque, Michael Pugliese, Jess G. Fiedorowicz, André J. McDonald, Joshua D. Rosenblat, Ian Colman, Josephine Zein, Marco Solmi   +9 more
wiley   +1 more source

Neuroimaging and the Investigation of Drug-Drug Interactions Involving Psychedelics

Neuroscience Insights
Psychedelic therapies are an emerging class of treatments in psychiatry with great potential, however relatively little is known about their interactions with other commonly used psychiatric medications.
Matthew B Wall, Rebecca Harding, Natalie Ertl, Tommaso Barba, Rayyan Zafar, Mark Sweeney, David J Nutt, Eugenii A Rabiner, David Erritzoe   +8 more
doaj   +1 more source

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial

BJPsych Open
Background Major depressive disorder (MDD) is the leading cause of disability worldwide, affecting roughly 322 million people. Recently, doses of psilocybin have shown promise in treating mood disorders, sparking interest in other dosing practices ...
Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, Thomas Anderson, Emily Fewster, Omer A. Syed, Valentyne Sobolenko, Ismail Kaan Kanca, Magdalena Jaglinska, Tatiana Son, Norman Farb, Rotem Petranker   +11 more
doaj   +1 more source